Neuronetics Inc (STIM)
3.83
-0.13
(-3.28%)
USD |
NASDAQ |
Apr 18, 16:00
3.83
0.00 (0.00%)
After-Hours: 20:00
Neuronetics Cash from Financing (TTM): 22.70M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 22.70M |
September 30, 2023 | 0.682M |
June 30, 2023 | 0.682M |
March 31, 2023 | 0.754M |
December 31, 2022 | 0.207M |
September 30, 2022 | -0.006M |
June 30, 2022 | 0.094M |
March 31, 2022 | 0.795M |
December 31, 2021 | 83.01M |
September 30, 2021 | 83.03M |
June 30, 2021 | 83.34M |
March 31, 2021 | 82.68M |
December 31, 2020 | 2.369M |
Date | Value |
---|---|
September 30, 2020 | 2.413M |
June 30, 2020 | 2.446M |
March 31, 2020 | 2.868M |
December 31, 2019 | 2.42M |
September 30, 2019 | 2.78M |
June 30, 2019 | 99.61M |
March 31, 2019 | 98.64M |
December 31, 2018 | 97.04M |
September 30, 2018 | 101.58M |
June 30, 2018 | 4.326M |
March 31, 2018 | 19.66M |
December 31, 2017 | 23.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.006M
Minimum
Sep 2022
99.61M
Maximum
Jun 2019
24.89M
Average
2.42M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Delcath Systems Inc | 51.78M |
Star Equity Holdings Inc | -3.072M |
Exact Sciences Corp | 159.77M |
CytoSorbents Corp | 14.47M |
Progyny Inc | -11.07M |